Biotechnology Services

These advisers say markets predict unrealistic outcomes. Here are some options.

WuXi XDC units its Hong Kong IPO value at excessive finish of vary

Stock movers: Snapchat, Theseus Pharmaceuticals, Azenta, Beauty Health, Fisker

AstraZeneca hikes earnings forecast as surging most cancers drug gross sales offset plunging income from COVID vaccines

U.S. shares set to open greater after Amazon earnings, inflation knowledge

Biogen and Eisai launch new Alzheimer’s drug knowledge which will help wider uptake

SolarEdge expects ‘considerably decrease’ income and gross sales; inventory drops 19%

Ardelyx wins lengthy battle for FDA approval of kidney-disease remedy 

Pfizer shares fall on steerage reduce, weighing on BioNTech and Moderna shares, and different shares on the transfer

Pfizer’s inventory sinks after firm slashes $9 billion from outlook, foreshadows layoffs